Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXUE2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,416
Award facts
- Contract value 100% obligated
- $15,416.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 15, 2026, the Defense Logistics Agency awarded a $15,416.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gardasil 9 vaccine syringes (0.5ML). This non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order exemplifies the Defense Logistics Agency's ongoing pharmaceutical supply chain operations, which distribute essential medications and medical supplies to support military treatment facilities and healthcare programs worldwide. As the parent company of AmerisourceBergen Drug Corp, Cencora, Inc. also maintains a larger IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. The contract award demonstrates AmerisourceBergen's capability to fulfill federal medical procurement requirements through open competition, providing a diverse portfolio of pharmaceutical products including specialty medications, vaccines, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FXUE2?
SPE2DR26FXUE2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FXUE2 worth?
The government has obligated $15,416 on SPE2DR26FXUE2.
Is contract SPE2DR26FXUE2 an order under another contract?
Yes. SPE2DR26FXUE2 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUE2 competed?
The extent of competition for SPE2DR26FXUE2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award